Chapter 023

Drugs for Treating Orofacial Pain Syndromes

Robert L. Merrill

CITED REFERENCES

  1. Binder WJ, Brin MF, Blitzer A, et al: Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 123:669-676, 2000. PUBMED Abstract
  2. Blommel ML, Blommel AL: Pregabalin: an antiepileptic agent useful for neuropathic pain. Am J Health Syst Pharm 64:1475-1482, 2007. PUBMED Abstract
  3. Brandes JL, Smith T, Diamond M, et al: Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine. Headache 47:886-894, 2007. PUBMED Abstract
  4. Chapman MA, Barron R, Tanis DC, et al: Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Clin Ther 29:1325-1337, 2007. PUBMED Abstract
  5. Cohen GL: Protriptyline, chronic tension-type headaches, and weight loss in women. Headache 37:433-436, 1997. PUBMED Abstract
  6. Cooper JR, Bloom FE, Roth RH: The biochemical basis of neuropharmacology, ed 7, New York, 1996, Oxford University Press.
  7. Dahlström A, Fuxe K: Evidence of the existence of monoamine-containing neurons in the central nervous system, I: demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiol Scand 62(Suppl 232):1-55, 1964. PUBMED Abstract
  8. Erspamer V, Asero B: Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169:801-802, 1952. PUBMED Abstract
  9. Esmann V, Geil JP, Kroon S, et al: Prednisolone does not prevent post-herpetic neuralgia. Lancet 2:126-129, 1987. PUBMED Abstract
  10. Field M, Hughes J, Singh L: Further evidence for the role of the α2δ subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 131:282-286, 2000. PUBMED Abstract
  11. Gaddum JH, Picarelli ZJ: Two kinds of tryptamine receptor. Br J Pharmacol 12:323-328, 1957. PUBMED Abstract
  12. Géraud G, Keywood C, Senard JM: Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Headache 43:376-388, 2003. PUBMED Abstract
  13. Ghelardini C, Galeotti N, Casamenti F, et al: Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8. Life Sci 58:2297-2309, 1996. PUBMED Abstract
  14. Goadsby PJ, Massiou H, Pascual J, et al: Almotriptan and zolmitriptan in the acute treatment of migraine. Acta Neurol Scand 115:34-40, 2007. PUBMED Abstract
  15. Göbel H, Heinze A, Heinze-Kuhn K, et al: Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 91:195-199, 2001. PUBMED Abstract
  16. Graff-Radford SB, Solberg WK: Atypical odontalgia. J Craniomandib Disord Facial Oral Pain 6:260-265, 1992. PUBMED Abstract
  17. Graham JR, Wolff HG: Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737-763, 1938.
  18. Hamlin K, Fischer F: The synthesis of 5-hydroxytryptamine. J Am Chem Soc 73:5007-5008, 1951.
  19. Hirst GR, Watkins AJ, Guerrero K, et al: Botulinum toxin B is not an effective treatment of refractory overactive bladder. Urology 69:69-73, 2007. PUBMED Abstract
  20. Janeway T, Richardson H, Park E: Experiments on the vasoconstrictor action of blood serum. Arch Intern Med 563-603, 1918.
  21. Johnson KW, Phebus LA, Cohen ML: Serotonin in migraine: theories, animal models and emerging therapies. Prog Drug Res 51:219-244, 1998. PUBMED Abstract
  22. Keczkes K, Basheer AM: Do corticosteroids prevent post-herpetic neuralgia? Br J Dermatol 102:551-555, 1980. PUBMED Abstract
  23. Kranz G, Sycha T, Voller B, et al: Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions. Dermatol Surg 32:886-890, 2006. PUBMED Abstract
  24. Kwiat GC, Basbaum AI: The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat. Somatosens Mot Res 9:157-173, 1992. PUBMED Abstract
  25. Lang E, Hord AH, Denson D: Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain 68:151-155, 1996. PUBMED Abstract
  26. Leniger T, Wiemann M, Bingmann D, et al: Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells-implication for their potency in migraine therapy. Cephalalgia 20:533-537, 2000. PUBMED Abstract
  27. Macdonald RL, Kelly KM: Antiepileptic drug mechanisms of action. Epilepsia 36(Suppl 2):S2-S12, 1995. PUBMED Abstract
  28. Morgan MM, Sohn JH, Liebeskind JC: Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level. Brain Res 502:61-66, 1989. PUBMED Abstract
  29. Moskowitz MA: Basic mechanisms in vascular headache. Neurol Clin 8:801-815, 1990. PUBMED Abstract
  30. Moskowitz MA: The trigeminovascular system. In Olesen J, Tfelt-Hansen P, editors: The headaches, New York, 1993, Raven Press.
  31. Nohr D, Schafer MK-H, Persson S, et al: Calcitonin gene-related peptide gene expression in collagen-induced arthritis is differentially regulated in primary afferents and motoneurons: influence of glucocorticoids. Neuroscience 93:759-773, 1999. PUBMED Abstract
  32. Onghena P, Van Houdenhove B: Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 49:201-219, 1992. PUBMED Abstract
  33. Pappert EJ, Germanson T: Myobloc/Neurobloc European Cervical Dystonia Study Group: Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: randomized, double-blind, noninferiority trial. Mov Disord 23:510-517, 2008. PUBMED Abstract
  34. Porta M: A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85:101-105, 2000. PUBMED Abstract
  35. Powell KR, Dykstra LA: The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure. Psychopharmacology 126:42-49, 1996. PUBMED Abstract
  36. Rapport M, Green A, Page I: Serum vasoconstrictor (serotonin), IV: isolation and characterization. J Biol Chem 176:1243-1251, 1948.
  37. Rossi RP, Strax TE, Di Rocco A: Severe dysphagia after botulinum toxin B injection to the lower limbs and lumbar paraspinal muscles. Am J Phys Med Rehabil 85:1011-1013, 2006. PUBMED Abstract
  38. Saper JR, Winner PK, Lake AE: An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache. Headache 41:357-368, 2001. PUBMED Abstract
  39. Saxena PR: Historical aspects of 5-hydroxytryptamine: discovery and receptor classification. In Olesen J, Saxena PR, editors: 5-Hydroxytryptamine mechanisms in primary headaches, New York, 1992, Raven Press.
  40. Sicuteri F, Testi A, Anselmi B: Biochemical investigations in headache increase in hydroxyindoleacetic acid excretion during migraine attacks. Arch Allergy Appl Immunol 19:55-58, 1961.
  41. Stepien A, Chalimoniuk M, Strosznajder J: Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices. Cephalalgia 19:859-865, 1999. PUBMED Abstract
  42. Taiwo YO, Levine JD: Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 48:485-490, 1992. PUBMED Abstract
  43. Taylor AP, Adelman JU, Freeman MC: Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart review. Headache 47:1200-1203, 2007. PUBMED Abstract
  44. Tremont-Lukats IW, Megeff C, Backonja MM: Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 60:1029-1052, 2000. PUBMED Abstract

GENERAL REFERENCES

  1. Cooper JR, Bloom FE, Roth RH: Serotonin (5-hydroxytryptamine), histamine and adenosine. In The biochemical basis of neuropharmacology, ed 8, New York, 2003, Oxford University Press.
  2. Evans RW, Mathew NT: Handbook of headache, Philadelphia, 2000, Lippincott Williams & Wilkins.
  3. Ferrari MD: Systemic biochemistry. In Olesen J, Tfelt-Hansen P, Welch KMA, editors: The headaches, New York, 1993, Raven Press.
  4. Frazer A, Hensler JG: Serotonin. In Siegel GJ, Agranoff BW, Albers RW, et al, editors: Basic neurochemistry: molecular, cellular and medical aspects, ed 6, Philadelphia, 1999, Lippincott-Raven.
  5. Saper JR, Silberstein SD, Gordon CD, et al, editors: Handbook of headache management: a practical guide to diagnosis and treatment of head, neck and facial pain, ed 2, Philadelphia, 1999, Lippincott Williams & Wilkins.
  6. Saper JR, Silberstein SD, Gordon CD, et al: Treatment of intractable, severe migraine: parenteral treatment protocols, hospitalization, and referral guidelines. In Saper JR, Silberstein SD, Gordon CD, et al, editors: Handbook of headache management: a practical guide to diagnosis and treatment of head, neck and facial pain, ed 2, Philadelphia, 1999, Lippincott Williams & Wilkins.